In 59 overweight/obese patients with AF awaiting ablation, adding liraglutide to risk factor modification for 3 months did not change the primary outcome, left atrial epicardial fat volume, vs modification alone. Secondary: 1-year freedom from AF 81% vs 54%.
RCTn = 59
Goldberger et al. The Liraglutide Effects in Atrial Fibrillation (LEAF) Study